$1.17
-0.16-11.74%
In chiusura: Nov 20, 4:00 PM EST
$1.16
-0.0095-0.82%
Post-mercato: 6:11 PM EST

The average analyst price target for Century Therapeutics is $7.29, 530.9% above the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $2 to $24. The latest change came on May 27, 2026, when Mizuho initiated coverage of Century Therapeutics with an Outperform rating and a $8 price target.
Price Target Range — 10 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months